Buruli Ulcer, Susceptibility To

Description

Buruli ulcer is an infectious disease prevalent in many tropical and subtropical regions caused by infection with Mycobacterium ulcerans. It is the third most frequent mycobacterial disease in humans worldwide, after tuberculosis (OMIM ) and leprosy (OMIM ). Lesions are most common on exposed parts of the body, especially the limbs. Buruli ulcer derives its name from a county in Uganda, East Africa, north of Kampala, where the disease was found in the late 1950s in hundreds of people living near marshes and riverine areas near the Nile River (Clancey et al., 1961; Barker, 1971). The disease was first described in the medical literature in 1948 in a report on patients in Australia (MacCallum et al., 1948). Patients have also been reported from tropical areas in Latin America and Asia (Stienstra et al., 2006; van der Werf et al., 2005).

Clinical Features

Phenotypes and symptoms related to Buruli Ulcer, Susceptibility To

  • Edema

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
No data available about the known clinical features onset.

Alternative names

Buruli Ulcer, Susceptibility To Is also known as mycobacterium ulcerans, susceptibility to.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Buruli Ulcer, Susceptibility To Recommended genes panels

Panel Name, Specifity and genes Tested/covered
SLC11A1.

By Fulgent Genetics Fulgent Genetics (United States).

SLC11A1
Specificity
100 %
Genes
100 %

You can get up to -7 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SCLEROSTEOSIS 2; SOST2 SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA ESTROGEN RESISTANCE; ESTRR HEIMLER SYNDROME 1; HMLR1 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H DWARFISM WITH TALL VERTEBRAE